- ORAL COMPOSITIONS FOR REDUCING DENTAL STAINS
-
Disclosed are compositions and formulations for reducing or removing tooth stains. The composition comprise one or more compounds having the formula where R is where n=1 to 11, in an orally acceptable carrier. Also disclosed are methods of making and use the compounds in oral formulations.
- -
-
Paragraph 0040-0049
(2018/12/11)
-
- In vitro studies of lanthanide complexes for the treatment of osteoporosis
-
Lanthanide ions, Ln(iii), are of interest in the treatment of bone density disorders because they are found to accumulate preferentially in bone (in vivo), have a stimulatory effect on bone formation, and exhibit an inhibitory effect on bone degradation (in vitro), altering the homeostasis of the bone cycle. In an effort to develop an orally active lanthanide drug, a series of 3-hydroxy-4-pyridinone ligands were synthesized and eight of these ligands (H1 = 3-hydroxy-2-methyl-1-(2-hydroxyethyl)-4-pyridinone, H2 = 3-hydroxy-2-methyl-1- (3-hydroxypropyl)-4-pyridinone, H3 = 3-hydroxy-2-methyl-1-(4-hydroxybutyl)-4- pyridinone, H4 = 3-hydroxy-2-methyl-1-(2-hydroxypropyl)-4-pyridinone, H5 = 3-hydroxy-2-methyl-1-(1-hydroxy-3-methylbutan-2-yl)-4-pyridinone, H6 = 3-hydroxy-2-methyl-1-(1-hydroxybutan-2-yl)-4-pyridinone, H7 = 1-carboxymethyl-3-hydroxy-2-methyl-4-pyridinone, H8 = 1-carboxyethyl-3-hydroxy- 2-methyl-4-pyridinone) were coordinated to Ln3+ (Ln = La, Eu, Gd, Lu) forming stable tris-ligand complexes (LnL3, L = 1-, 2-, 3-, 4-, 5-, 6-, 7- and 8-). The dissociation (pKan) and metal ligand stability constants (log βn) of the 3-hydroxy-4- pyridinones with La3+ and Gd3+ were determined by potentiometric titrations, which demonstrated that the 3-hydroxy-4-pyridinones form stable tris-ligand complexes with the lanthanide ions. One phosphinate-EDTA derivative (H5XT = bis[[bis(carboxymethyl)amino]methyl]phosphinate) was also synthesized and coordinated to Ln3+ (Ln = La, Eu, Lu), forming the potassium salt of [Ln(XT)]2-. Cytotoxicity assays were carried out in MG-63 cells; all the ligands and metal complexes tested were observed to be non-toxic to this cell line. Studies to investigate the toxicity, cellular uptake and apparent permeability (Papp) of the lanthanide ions were conducted in Caco-2 cells where it was observed that [La(XT)] 2- had the greatest cell uptake. Binding affinities of free lanthanide ions (Ln = La, Gd and Lu), metal complexes and free 3-hydroxy-4-pyridinones with the bone mineral hydroxyapatite (HAP) are high, as well as moderate to strong for the free ligand with the bone mineral depending on the functional group.
- Mawani, Yasmin,Cawthray, Jacqueline F.,Chang, Stanley,Sachs-Barrable, Kristina,Weekes, David M.,Wasan, Kishor M.,Orvig, Chris
-
supporting information
p. 5999 - 6011
(2013/06/27)
-
- Conjugates of desferrioxamine B (DFOB) with derivatives of adamantane or with orally available chelators as potential agents for treating iron overload
-
Desferrioxamine B (DFOB) conjugates with adamantane-1-carboxylic acid, 3-hydroxyadamantane-1-carboxylic acid, 3,5-dimethyladamantane-1-carboxylic acid, adamantane-1-acetic acid, 4-methylphenoxyacetic acid, 3-hydroxy-2-methyl-4-oxo- 1-pyridineacetic acid (
- Liu, Joe,Obando, Daniel,Schipanski, Liam G.,Groebler, Ludwig K.,Witting, Paul K.,Kalinowski, Danuta S.,Richardson, Des R.,Codd, Rachel
-
experimental part
p. 1370 - 1382
(2010/08/20)
-
- Synthesis of N-Substituted 3-Hydroxy-2-methyl-4-pyridones and -pyridonimines
-
Carbohydrates with 1,4-glycoside bonds like maltose, lactose, dextrin or strach react with primary amines as well as amino acids or proteins to give i.e. 3-hydroxy-2-methyl-4-pyridones 5 and 3-hydroxy-2-methyl-4-pyridonimines 7.A generally applicable synt
- Faerber, M.,Osiander, H.,Severin, T.
-
p. 947 - 956
(2007/10/02)
-
- Physical and structural studies of N-carboxymethyl- and N-(p-methoxyphenyl)-3-hydroxy-2-methyl-4-pyridinone
-
3-hydroxy-1-carboxymethyl-2-methyl-4-pyridinone (Hcmp) and 3-hydroxy-1-(p-methoxyphenyl)-2-methyl-4-pyridine (Hpap) have been prepared and studied by single crystal X-ray diffraction.Crystals of Hcmp are monoclinic, a = 6.340(2), b = 7.705(1), c = 16.226(
- Zhang, Zaihui,Rettig, Steven J.,Orvig, Chris
-
p. 763 - 770
(2007/10/02)
-
- Iron-pyridone complexes for anemia
-
Pharmaceutical compositions containing an iron complex of a 3-hydroxypyrid-2-one or 3-hydroxypyrid-4-one in which the hydrogen atom attached to the nitrogen atom is replaced by an aliphatic acyl group, by an aliphatic hydrocarbon group, or by an aliphatic hydrocarbon group substituted by one or, except in the case of ionizable groups, more than one substituent selected from aliphatic acyl, alkoxy, aliphatic amine, aliphatic amide, carboxy, aliphatic ester, halogen, hydroxy and sulpho groups and, optionally, in which one or more of the hydrogen atoms attached to ring carbon atoms are replaced by one of said substituents, by an aliphatic hydrocarbon group, or by an aliphatic hydrocarbon group substituted by an alkoxy, aliphatic ester, halogen or hydroxy group, but excluding compounds in which said replacement of hydrogen atoms in the compound is effected only by aliphatic hydrocarbon groups, are of value for the treatment of iron deficiency anemia.
- -
-
-
- Pharmaceutical compositions
-
Pharmaceutical compositions containing a 3-hydroxypyrid-2-one or 3-hydroxypyrid-4-one in which the hydrogen atom attached to the nitrogen atom is replaced by an aliphatic acyl group, by an aliphatic hydrocarbon group, or by an aliphatic hydrocarbon group substituted by one or, except in the case of ionizable groups, more than one substituent selected from aliphatic acyl, alkoxy, aliphatic amine, aliphatic amide, carboxy, aliphatic ester, halogen, hydroxy and sulpho groups and, optionally, in which one or more of the hydrogen atoms attached to ring carbon atoms are replaced by one of said substituents, by an aliphatic hydrocarbon group, or by an aliphatic hydrocarbon group substituted by an alkoxy, aliphatic ester, halogen or hydroxy group, but excluding compounds in which said replacement of hydrogen atoms in the compound is effected only by aliphatic hydrocarbon groups, or a salt thereof containing a physiologically acceptable ion or ions, are of value for removing toxic amounts of metals, particularly iron, from the body.
- -
-
-